• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用干细胞治疗女性生殖和内分泌功能障碍。

Therapeutic restoration of female reproductive and endocrine dysfunction using stem cells.

机构信息

The Laboratory of Cancer Precision Medicine, the First Hospital of Jilin University, Changchun, Jilin 130061, China.

The Laboratory of Cancer Precision Medicine, the First Hospital of Jilin University, Changchun, Jilin 130061, China; Department of Gynecologic Oncology, Gynecology and Obstetrics Centre, the First Hospital of Jilin University, Changchun, Jilin 130012, China.

出版信息

Life Sci. 2023 Jun 1;322:121658. doi: 10.1016/j.lfs.2023.121658. Epub 2023 Apr 4.

DOI:10.1016/j.lfs.2023.121658
PMID:37023951
Abstract

Millions of women worldwide suffer from infertility associated with gynecologic disorders such as premature ovarian insufficiency, polycystic ovary syndrome, Asherman syndrome, endometriosis, preeclampsia, and fallopian tube obstruction. These disorders can lead to infertility and thereby affect the quality of life of the infertile couple because of their psychological impact and significant costs. In recent years, stem cell therapy has emerged as a therapeutic approach to repair or replace damaged tissues or organs. This review describes the recent development as well as the underlying mechanisms of stem cell therapy for a variety of female reproductive diseases, offering us new therapeutic options for the treatment of female reproductive and endocrine dysfunction.

摘要

全世界数以百万计的女性患有与妇科疾病相关的不孕症,例如卵巢早衰、多囊卵巢综合征、Asherman 综合征、子宫内膜异位症、子痫前期和输卵管阻塞。这些疾病会导致不孕,从而影响不孕夫妇的生活质量,因为它们会带来心理影响和巨大的经济负担。近年来,干细胞疗法已成为修复或替代受损组织或器官的治疗方法。本综述描述了干细胞疗法治疗各种女性生殖疾病的最新进展及其潜在机制,为治疗女性生殖和内分泌功能障碍提供了新的治疗选择。

相似文献

1
Therapeutic restoration of female reproductive and endocrine dysfunction using stem cells.利用干细胞治疗女性生殖和内分泌功能障碍。
Life Sci. 2023 Jun 1;322:121658. doi: 10.1016/j.lfs.2023.121658. Epub 2023 Apr 4.
2
Therapeutic roles of platelet-rich plasma to restore female reproductive and endocrine dysfunction.富血小板血浆在恢复女性生殖和内分泌功能障碍方面的治疗作用。
Front Endocrinol (Lausanne). 2024 Apr 9;15:1374382. doi: 10.3389/fendo.2024.1374382. eCollection 2024.
3
[Treatment of infertility in women with polycystic ovary syndrome].[多囊卵巢综合征女性不孕症的治疗]
Rev Bras Ginecol Obstet. 2008 Apr;30(4):201-9. doi: 10.1590/s0100-72032008000400008.
4
Mesenchymal Stem Cell-based Therapy and Female Infertility: Limitations and Advances.基于间充质干细胞的疗法与女性不孕症:局限与进展
Curr Stem Cell Res Ther. 2023;18(3):322-338. doi: 10.2174/1574888X17666220511142930.
5
Mesenchymal Stem Cells as a Bio Organ for Treatment of Female Infertility.间充质干细胞作为治疗女性不孕症的生物器官
Cells. 2020 Oct 8;9(10):2253. doi: 10.3390/cells9102253.
6
A brief update on the evidence supporting the treatment of infertility in polycystic ovary syndrome.关于支持多囊卵巢综合征不孕症治疗证据的简要更新。
Aust N Z J Obstet Gynaecol. 2019 Dec;59(6):867-873. doi: 10.1111/ajo.13051. Epub 2019 Sep 12.
7
Exploring the future potential of mesenchymal stem/stromal cells and their derivatives to support assisted reproductive technology for female infertility applications.探讨间充质干细胞及其衍生细胞在支持女性不孕不育应用的辅助生殖技术方面的未来潜力。
Hum Cell. 2023 Sep;36(5):1604-1619. doi: 10.1007/s13577-023-00941-3. Epub 2023 Jul 5.
8
Prospective evaluation of basal stromal Doppler studies in women with good ovarian reserve and infertility undergoing in vitro fertilization-embryo transfer treatment: patients with polycystic ovary syndrome versus ovulatory patients.对卵巢储备功能良好且患有不孕症行体外受精-胚胎移植治疗的女性进行基础窦卵泡多普勒研究的前瞻性评估:多囊卵巢综合征患者与排卵患者。
Fertil Steril. 2011 Apr;95(5):1754-8. doi: 10.1016/j.fertnstert.2011.01.007.
9
Laparoscopic surgery for infertility therapy.用于不孕症治疗的腹腔镜手术。
Curr Opin Obstet Gynecol. 1994 Apr;6(2):141-8.
10
Independent Variables for Determining the Cumulative Live Birth Rates of Aged Patients with Polycystic Ovary Syndrome or Tubal Factor Infertility: A Retrospective Cohort Study.用于确定高龄多囊卵巢综合征或输卵管性不孕患者累积活产率的自变量:一项回顾性队列研究。
Front Endocrinol (Lausanne). 2022 Jan 17;12:728051. doi: 10.3389/fendo.2021.728051. eCollection 2021.

引用本文的文献

1
Assisted Reproductive Technology: A Ray of Hope for Infertility.辅助生殖技术:不孕症患者的一线希望。
ACS Omega. 2025 May 23;10(22):22347-22365. doi: 10.1021/acsomega.5c01643. eCollection 2025 Jun 10.
2
Mesenchymal stem cells and mesenchymal stem cell-derived exosomes: attractive therapeutic approaches for female reproductive dysfunction.间充质干细胞及其衍生的外泌体:治疗女性生殖功能障碍的有吸引力的治疗方法。
Mol Biol Rep. 2024 Nov 22;52(1):10. doi: 10.1007/s11033-024-10106-6.
3
Translational potential of mesenchymal stem cells in regenerative therapies for human diseases: challenges and opportunities.
间充质干细胞在人类疾病再生治疗中的转化潜力:挑战与机遇。
Stem Cell Res Ther. 2024 Aug 26;15(1):266. doi: 10.1186/s13287-024-03885-z.
4
Horizons in Endometriosis: Proceedings of the Montreux Reproductive Summit, 14-15 July 2023.子宫内膜异位症新视野:2023年7月14 - 15日蒙特勒生殖峰会会议论文集
Facts Views Vis Obgyn. 2024 Apr 11;16(16 Suppl 1):1-32. doi: 10.52054/FVVO.16.s1.011.